Quick Answer
Replimune Group, Inc. reported Stockholders Equity of $415.84 million for the year ending 2025.
- Replimune Group, Inc. showed an increase of +11.0% in Stockholders Equity from 2024 to 2025.
- This data is from Replimune Group, Inc.'s annual report (Form 10-K), filed with the SEC on May 22, 2025.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: -$38.70 million | Q3 2018: $150.04 million | Q4 2018: $143.24 million | Q2 2019: $130.15 million | Q3 2019: $120.64 million | Q4 2019: $197.57 million | Q2 2020: $277.81 million | Q3 2020: $261.39 million | Q4 2020: $516.20 million | Q2 2021: $479.02 million | Q3 2021: $457.41 million | Q4 2021: $437.51 million | Q2 2022: $410.26 million | Q3 2022: $384.07 million | Q4 2022: $595.35 million | Q2 2023: $514.03 million | Q3 2023: $465.17 million | Q4 2023: $421.54 million | Q1 2024: $374.51 million | Q2 2024: $426.45 million | Q3 2024: $381.46 million | Q4 2024: $482.37 million | Q1 2025: $415.84 million | Q2 2025: $336.72 million | Q3 2025: $263.34 million | Q4 2025: $210.54 million.
- Over the full 9 years of available data (2017 to 2025), Replimune Group, Inc.'s Stockholders Equity has grown by 3,711.3%.
- Historical annual values: Fiscal year 2025: $415.84 million | Fiscal year 2024: $374.51 million | Fiscal year 2023: $555.29 million | Fiscal year 2022: $411.23 million | Fiscal year 2021: $498.73 million | Fiscal year 2020: $183.72 million | Fiscal year 2019: $137.86 million | Fiscal year 2018: -$28.07 million | Fiscal year 2017: -$11.52 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: